Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-03-30
2011-12-27
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S362500
Reexamination Certificate
active
08084485
ABSTRACT:
6-(Aminoalkyl)indazoles of formula (I) and the salts thereof have renin-inhibiting properties and can be used as antihypertensive, and renal, cardiac and vascular protecting medicinally active ingredients.
REFERENCES:
patent: 5627182 (1997-05-01), Göschke et al.
patent: WO 97/09311 (1997-03-01), None
patent: WO 99/23077 (1999-05-01), None
patent: WO 03/050073 (2003-06-01), None
patent: WO 2005/070877 (2005-08-01), None
patent: WO 2006/083924 (2006-08-01), None
patent: WO 2007/031558 (2007-03-01), None
patent: WO 2007/120523 (2007-10-01), None
patent: WO 2007/123718 (2007-11-01), None
Wood, J., et al., “Structure-based Design of Aliskiren, a Novel Orally Effective Renin Inhibitor,”Biochemical and Biophysical Research Communications,308(4): 698-705 (2003).
PCT International Search Report from PCT/US2007/007961, Dated: Sep. 28, 2007.
PCT Written Opinion of the International Searching Authority from PCT/US2007/007961, Dated: Sep. 28, 2007.
PCT International Preliminary Report on Patentability from PCT/US2007/007961, Dated: Oct. 9, 2008.
PCT International Search Report from PCT/US2006/003489, Dated: Jun. 20, 2006.
PCT Written Opinion of the International Searching Authority from PCT/US2006/003489, Dated: Jun. 20, 2006.
PCT International Preliminary Report on Patentability from PCT/US2006/003489, Dated: Aug. 16, 2007.
PCT International Preliminary Report on Patentability from PCT/US2007/008180, Dated: Oct. 9, 2008.
PCT International Search Report, Nov. 2, 2007, PCT/US2007/008180.
PCT Written Opinion of the International Searching Authority, Nov. 2, 2007, PCT/US2007/008180.
United States Patent and Trademark Office, Restriction Requirement dated Sep. 14, 2011, U.S. Appl. No. 11/883,518.
United States Patent and Trademark Office, Restriction Requirement dated Nov. 1, 2011, U.S. Appl. No. 12/225,757.
United States Patent and Trademark Office, Restriction Requirement dated Nov. 10, 2011, U.S. Appl. No. 11/883,518.
Baldwin John J.
Claremon David A.
Dillard Lawrence W.
Ishchenko Alexey V.
McGeehan Gerard
Anderson Rebecca
Hamilton Brook Smith & Reynolds P.C.
Shterengarts Samantha
Vitae Pharmaceuticals, Inc.
LandOfFree
6-(aminoalkyl)indazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6-(aminoalkyl)indazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-(aminoalkyl)indazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4315012